UNSPSC 51111772: Vinorelbine

This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C45H54N4O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q6C979R91Y, chemically known as c-norvincaleukoblastine, 3,4-didehydro-4-deoxy-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:2) (salt) but generally known as vinorelbine, which bears US NIH Compound Identifier 60779. European Medicines Agency schedules Vinorelbine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00069MIG.

UNSPSC 51111772 Vinorelbine is a Commodity code covering pharmaceutical products, but the recent state and local opportunities associated with this code show limited activity directly aligned with vinorelbine procurement. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—antibiotics rather than chemotherapy agents—over a 36-month period including renewals for $2,999,999.11. Seminole County, Florida issued an IFB for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries, neither of which relates to vinorelbine or cancer therapeutics. State and local buyers using this code primarily consist of health departments and county health agencies executing cooperative purchasing agreements and competitive sealed bids for pharmaceutical supply contracts with fixed pricing and multi-year renewal terms.

The geographic activity shown is limited to Illinois and Florida, with procurement occurring through established cooperative purchasing vehicles (MMCAP Infuse in Illinois) and direct county IFBs. The Illinois award closed on August 28, 2026, with a 12-month initial term and two optional renewal years; the Seminole County solicitation posted June 30, 2026, with a July 26, 2023, response deadline (a date inconsistency in the source record). The mismatch between the code's nominal scope—vinorelbine, a vinca alkaloid chemotherapy agent—and the actual recent buys (broad-spectrum antibiotics and overdose reversal drugs) suggests this code may see minimal procurement activity for vinorelbine specifically, or the posted opportunities reflect tagging errors. Absent evidence of recent vinorelbine-specific solicitations, activity under this Commodity code appears sparse and does not support a pursue decision based on the available record.